MN

Michael Nally

VC Partner, CEO/Partner at Flagship Pioneering

Location

United States, North America

Check Size

$500K - $15M

Investment Stage

Seed
Series A

Focus Areas

AI
BioTech
Pharmaceuticals

About Investor

Michael Nally serves as CEO-Partner at Flagship Pioneering and Chief Executive Officer of Generate:Biomedicines, focusing on investments ranging from $500K to $15.0M in Pharmaceuticals, BioTech, and AI companies at seed and Series A stages. His geographic focus is Boston/New England. Nally joined Flagship in 2021 and brings extensive experience in leading global pharmaceutical organizations with a deep commitment to innovation and patient care.

Looking for investors like Michael Nally?
Get matched with the right ones for your startup.

Explore more investors

Previous investments

Generate Biomedicines
270M |2023
370M |2021

Similar Investors

AL

Abdul Ly

United States, North America
$1M - $4M

Seed

,

Series A

,
PS

Paul Straub

United States, North America
$100K - $2M

Pre Seed

,

Seed

,
SA

Shaun Abrahamson

United States, North America
$250K - $1M

Pre Seed

,

Seed

,
RF

Riley Florsheim

United States, North America
$100K - $5M

Pre Seed

,

Seed

,
SB

Steve Brownlie

United States, North America
$250K - $1.4M

Pre Seed

,

Seed

,
JR

JJ Richa

United States, North America
$50K - $1M

Pre Seed

,

Seed

,

Is this You?

Is this you? Have any edits?
Fill out our update request form and we'll update ASAP

Grow with the Right Investors

This profile is just one example. Our AI matches you with the investors who best fit your stage, industry, and vision.

Start Matching For Free